BrightOwl Loader Loading


A Business Development professional with a strong scientific background and broad experience gained from roles in both the academic and pharmaceutical sectors, adept at both searching for and evaluating early and late stage/commercial opportunities, and leading cross functional teams in the negotiation and close of licensing or collaborative deals through to the subsequent management of strategic alliances.


Current Experience

  • Associate Director, European Business Development
    Since April 2015
    A key member of the Global Business Development and Strategy team, I'm responsible for leading the business development activities for the European Oncology and Transplant franchises working closely with the commercial teams to define strategic areas for partnering and identify and evaluate suitable late stage clinical candidates and on-market products for in-licensing or acquisition. I take the lead in managing the due diligence process utilizing cross functional teams (e.g. clinical, regulatory, legal, market access, commercial) and leading the presentation of selected opportunities to senior management for approval and in the negotiation and execution of term sheets and contracts in collaboration with legal and other functional teams.

Past Experience

  • Alliance Manager, European Business Development
    October 2013 --- March 2015
    Responsibility for managing the strategic alliances with other pharma companies in Europe and RoW on five existing commercial contracts/ agreements across all therapeutic areas within the Specialty business. This involved working with multiple internal stakeholders across different functional teams from the Specialty organization to suggest win-win solutions to optimise existing contracts and conducting negotiations with external partners that led to the modification of contracts including: - Negotiation of significant amendments to a Global Cooperation Agreement with another pharma company - The early termination to a commercial contract without any negative impact.

  • Business Development Manager
    January 2010 --- September 2013
    Searching and evaluating new technologies, drug targets and preclinical drug discovery small molecule or antibody projects originating from academic, biotech or pharmaceutical research in Europe and US for collaborative development or in-licensing. The promotion of MRC Technology’s resources and capabilities in drug discovery to leading academic scientists via seminars and university roadshows at the top thirty UK and selected US and European universities leading to approximately 100 project submissions per year Responsible for in-licensing from universities/biotechs and out-licensing of assets to pharma/biotech including attending partnering conferences and leading discussions with third parties through to deal closure for three collaborative development projects

  • Therapeutics Review Team Leader
    January 2012 --- December 2012
    Leading a team responsible for evaluating the scientific and commercial potential of new and existing drug discovery opportunities for internal development Coordination and management of due diligence for approximately 30 small molecule or antibody drug discovery projects each year across a broad range of therapeutic areas working in collaboration with leading academic and pharma external scientists and internal R&D scientists Chairing and organisation of bi-monthly drug target assessment meetings with senior R&D representatives to facilitate internal decision making on projects for progression

  • Business Manager
    April 2008 --- October 2010
    Identification, management and valuation of a diverse portfolio of MRC owned intellectual property Development of appropriate commercialisation strategies and marketing of licensing opportunities to partners

  • Post-doctoral scientist
    October 2007 --- April 2008

  • Scientific Officer
    October 2006 --- August 2007

  • Industrial Placement Student
    September 2000 --- August 2001


LinkedIn Assessment :
Commercial AssessmentCancermolecular biologyoncologyGeneticsCommercializationPharmaceutical IndustryLife SciencesDrug DiscoveryTechnology transferLifesciencesBiotechnologyBiochemistryBusiness DevelopmentLicensingBusiness AlliancesPartnershipsContract ManagementIntellectual PropertyNegotiationPatentsDue Diligence


  • Doctor of Philosophy (PhD) in Biochemistry and Molecular Biology from The Institute of Cancer Research, U. of London in 2007
  • Bachelor of Science (BSc) in Biochemistry and Physiology (Industry) from University of Leeds in 2002

Area / Region

Amsterdam, Netherlands


Driving License
  • No